Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 1467335 in NASH
NCT03166735Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of PXS-4728A in Nonalcoholic steatohepatitis (NASH), sponsored by Boehringer Ingelheim. Started Jun 2017; status: completed.
02
Drugs
PXS-4728A
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT03166735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03166735.